基于蒙特卡罗方法的复合材料辐射屏蔽设计北大核心CSCD

在乏燃料后处理厂的工作环境中可能存在着低能中子-γ射线混合辐射,严重威胁工作人员的人身安全。本文针对上述混合辐射环境,利用蒙特卡罗程序Geant4模拟计算了一种钨/硼纤维增强含硼/铋聚合物复合材料中不同材料参数对低能中子和γ射线综合防护效果的影响。结果显示,此种钨/硼纤维复合材料对低能中子和γ射线均具有良好的屏蔽效果。文章证实了纤维垂直排布方式具有比平行排布方式更优的屏蔽效果,且垂直排布方式下透过粒子束的强度分布更加均匀。此外,在聚合物基体中掺杂一定质量分数的硼/铋可以进一步增强复合材料的辐射屏蔽效果。依据这些结果我们认为此种复合材料可以为后处理厂等辐射环境中的防护服及相关防护用具提供参考。     

燃气轮机叶片材料0Cr17Ni4Cu4Nb砂带磨削性能研究

理论分析了在切除过程中磨粒与材料表面的交互作用机理,进行了砂带磨削燃气轮机叶片材料0Cr17Ni4Cu4Nb的试验研究,系统分析了各磨削工艺参数对材料切除率的影响规律,该研究对生产实践具有理论指导意义.     

2－氨基－4－氯苯酚的合成研究

提出了以对二氯苯为原料，经硝化，水解和还原三步合成２－氨基－４－氯苯酚的讨了影响反应的因素。产品总收率达７７％。     

Microstructure developed in the surface layer of Ti-6Al-4V alloy after sliding wear in vacuum

Microstructural changes in the surface layer of Ti-6Al-4V alloy after sliding wear in vacuum have been studied by means of scanning and transmission electron microscopy (SEM and TEM). The wear rates of Ti-6Al-4V alloy in vacuum were measured under different sliding velocities and loads. The experimental results showed that a severely deformed layer with a grain size of 50–100 nm and thickness about 70 μm was formed underneath the worn surface. Under the slower sliding velocities, the substructure of the layer had a high dislocation density, while under higher sliding velocities, twins were found to exist in the substructure. A process by which the deformed layer formed has been proposed and the deformation of materials at the contacting spots of the Ti-6Al-4V sample is discussed.     

一种新型的激光—等离子体辅助化学气相沉积装置的研究

为探索用激光离子体共同辅助化学气相沉积过程以实现室温沉积的可能性，设计并制造了一种新型的ＣＶＤ装置，实际了ＳｉＨ４－ＮＨ３－Ｎ２体系制取Ｓｉ３Ｎ４膜的试验。结果表明，激光和等离子体是可以相互促进，共同辅助ＣＶＤ过程的，且两者均处于较代的能量水平。     

A computer simulation of LiKSO4

Molecular-dynamics computer-simulation of an ionic molecular solid LiKSO₄ has been carried out at 300 and 1000 K using the atom-atom potentials obtained from lattice dynamical studies. We observe hopping of lithium ions to interstitial positions which is related to reorientations of sulphate tetrahedra.     

Near-Complete Remission of Glioblastoma in a Patient Treated with an Allogenic Dendritic Cell-Based Vaccine: The Role of Tumor-Specific CD4+T-Cell Cytokine Secretion Pattern in Predicting Response and Recurrence

Immunotherapy has brought hope to the fight against glioblastoma, but its efficacy remains unclear. We present the case of CST, a 25-year-old female patient with a large right-hemisphere glioblastoma treated with a dendritic–tumor cell fusion vaccine. CST showed a near-complete tumor response, with a marked improvement in her functional status and simultaneous increases in tumor-specific CD8+ and CD4+ T cells. Two months before recurrence, the frequency of tumor-specific T cells decreased, while that of IL-17 and CD4+ T cells increased. CST passed away 15 months after enrollment. In this illustrative case, the tumor-specific CD4+ T-cell numbers and phenotype behaved as treatment efficacy biomarkers, highlighting the key role of the latter in glioblastoma immunotherapy.     

4′-Methylflavanone Glycosides Obtained Using Biotransformation in the Entomopathogenic Filamentous Fungi Cultures as Potential Anticarcinogenic,Antimicrobial, and Hepatoprotective Agents

Flavonoid compounds exhibit numerous biological activities and significantly impact human health. The presence of methyl or glucosyl moieties attached to the flavonoid core remarkably modifies their physicochemical properties and improves intestinal absorption. Combined chemical and biotechnological methods can be applied to obtain such derivatives. In the presented study, 4′-methylflavanone was synthesized and biotransformed in the cultures of three strains of entomopathogenic filamentous fungi, i.e., Isaria fumosorosea KCH J2, Beauveria bassiana KCH J1.5, and Isaria farinosa KCH J2.1. The microbial transformation products in the culture of I. fumosorosea KCH J2, flavanone 4′-methylene-O-β-D-(4″-O-methyl)-glucopyranoside, 2-phenyl-(4′-hydroxymethyl)-4-hydroxychromane, and flavanone 4′-carboxylic acid were obtained. Biotransformation of 4′-methylflavanone in the culture of B. bassiana KCH J1.5 resulted in the formation of one main product, i.e., flavanone 4′-methylene-O-β-D-(4″-O-methyl)-glucopyranoside. In the case of I. farinosa KCH J2.6 as a biocatalyst, three products, i.e., flavanone 4′-methylene-O-β-D-(4″-O-methyl)-glucopyranoside, flavanone 4′-carboxylic acid, and 4′-hydroxymethylflavanone 4-O-β-D-(4″-O-methyl)-glucopyranoside were obtained. The Swiss-ADME online simulations confirmed the increase in water solubility of 4′-methylflavanone glycosides and analyses performed using the Way2Drug Pass Online prediction tool indicated that flavanone 4′-methylene-O-β-D-(4″-O-methyl)-glucopyranoside and 4′-hydroxymethylflavanone 4-O-β-D-(4″-O-methyl)-glucopyranoside, which had not been previously reported in the literature, are promising anticarcinogenic, antimicrobial, and hepatoprotective agents.     

The P2X4 Receptor: Cellular and Molecular Characteristics of a Promising Neuroinflammatory Target

The adenosine 5′-triphosphate-gated P2X4 receptor channel is a promising target in neuroinflammatory disorders, but the ability to effectively target these receptors in models of neuroinflammation has presented a constant challenge. As such, the exact role of P2X4 receptors and their cell signalling mechanisms in human physiology and pathophysiology still requires further elucidation. To this end, research into the molecular mechanisms of P2X4 receptor activation, modulation, and inhibition has continued to gain momentum in an attempt to further describe the role of P2X4 receptors in neuroinflammation and other disease settings. Here we provide an overview of the current understanding of the P2X4 receptor, including its expression and function in cells involved in neuroinflammatory signalling. We discuss the pharmacology of P2X4 receptors and provide an overview of P2X4-targeting molecules, including agonists, positive allosteric modulators, and antagonists. Finally, we discuss the use of P2X4 receptor modulators and antagonists in models of neuroinflammatory cell signalling and disease.     

HSPA4 Is a Biomarker of Placenta Accreta and Enhances the Angiogenesis Ability of Vessel Endothelial Cells

Placenta accreta spectrum (PAS) accounts for 7% of maternal mortality and is associated with intraoperative and postoperative morbidity caused by massive blood loss, infection, and adjacent organ damage. The aims of this study were to identify the protein biomarkers of PAS and to further explore their pathogenetic roles in PAS. For this purpose, we collected five placentas from pregnant subjects with PAS complications and another five placentas from normal pregnancy (NP) cases. Then, we enriched protein samples by specifically isolating the trophoblast villous, deeply invading into the uterine muscle layer in the PAS patients. Next, fluorescence-based two-dimensional difference gel electrophoresis (2D-DIGE) and MALDI-TOF/MS were used to identify the proteins differentially abundant between PAS and NP placenta tissues. As a result, nineteen spots were determined as differentially abundant proteins, ten and nine of which were more abundant in PAS and NP placenta tissues, respectively. Then, specific validation with western blot assay and immunohisto/cytochemistry (IHC) assay confirmed that heat shock 70 kDa protein 4 (HSPA4) and chorionic somatomammotropin hormone (CSH) were PAS protein biomarkers. Further tube formation assays demonstrated that HSPA4 promoted the in vitro angiogenesis ability of vessel endothelial cells, which is consistent with the in vivo scenario of PAS complications. In this study, we not only identified PAS protein biomarkers but also connected the promoted angiogenesis with placenta invasion, investigating the pathogenetic mechanism of PAS.